Treatment outcomes and unfavorable prognostic factors in patients with occult breast cancer

被引:60
|
作者
He, M. [1 ,2 ]
Tang, L. -C. [1 ,2 ]
Yu, K. -D. [1 ,2 ]
Cao, A. -Y. [1 ,2 ]
Shen, Z. -Z. [1 ,2 ]
Shao, Z. -M. [1 ,2 ]
Di, G. -H. [1 ,2 ]
机构
[1] Fudan Univ, Ctr Canc, Inst Canc, Dept Breast Surg, Shanghai 200032, Peoples R China
[2] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R China
来源
EJSO | 2012年 / 38卷 / 11期
关键词
Occult breast cancer; Clinical outcome; Prognostic factor; LYMPH-NODE METASTASES; CARCINOMA-IN-SITU; AXILLARY METASTASES; UNKNOWN PRIMARY; EXPERIENCE; MANAGEMENT; LYMPHADENOPATHY; BIOPSY; TUMORS;
D O I
10.1016/j.ejso.2012.08.022
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aims: The purpose of this study was to evaluate the treatment outcomes and prognostic factors in patients with occult breast cancer (OBC). Methods: We retrospectively analyzed 95 patients with OBC who were treated at our facility between January 1998 and June 2010. Of the 95 patients, 64 underwent mastectomy plus axillary lymph node dissection (ALND) with or without post-mastectomy radiation (Mast + ALND group), 13 underwent ALND followed by ipsilateral breast radiotherapy (BR + ALND group) and the remaining 18 were treated with ALND (ALND group). Results: Patients who underwent Mast + ALND or BR + ALND had significantly improved rates of locoregional recurrence-free survival (LRFS) and recurrence/metastasis-free survival (RFS) than patients who only underwent ALND (p < 0.05). There were no significant differences in the LRFS (p = 0.718), RFS (p = 0.935) and breast cancer-specific survival (BCSS) (p = 0.991) rates between the patients who underwent Mast + ALND compared with those who received BR + ALND. Multivariate analysis revealed that patients with four or more involved lymph nodes had significantly worse outcomes (p = 0.042, HR = 4.63, 95% CI = 1.66-32.47 for BCSS and p = 0.038, HR = 3.62, 95% CI = 1.08-20.77 for RFS). Conclusions: Patients with OBC who received ALND and subsequent breast radiotherapy had similar outcomes to patients who underwent mastectomy. The presence of four or more involved lymph nodes may independently predict poor outcomes of OBC. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1022 / 1028
页数:7
相关论文
共 50 条
  • [1] Prognostic Models Using Machine Learning Algorithms and Treatment Outcomes of Occult Breast Cancer Patients
    Qu, Jingkun
    Li, Chaofan
    Liu, Mengjie
    Wang, Yusheng
    Feng, Zeyao
    Li, Jia
    Wang, Weiwei
    Wu, Fei
    Zhang, Shuqun
    Zhao, Xixi
    [J]. JOURNAL OF CLINICAL MEDICINE, 2023, 12 (09)
  • [2] Treatment outcomes of occult breast carcinoma and prognostic analyses
    Wang Jing
    Zhang Ye-fan
    Wang Xin
    Wang Jian
    Yang Xue
    Gao Yin-qi
    Fang Yi
    [J]. CHINESE MEDICAL JOURNAL, 2013, 126 (16) : 3026 - 3029
  • [3] Treatment outcomes of occult breast carcinoma and prognostic analyses
    WANG Jing
    ZHANG Ye-fan
    WANG Xin
    WANG Jian
    YANG Xue
    GAO Yin-qi
    FANG Yi
    [J]. 中华医学杂志(英文版), 2013, (16) : 3026 - 3029
  • [4] Neuronal apoptosis inhibitory protein is overexpressed in patients with unfavorable prognostic factors in breast cancer
    Choi, Jaewon
    Hwang, Yu Kyeong
    Choi, Young Jin
    Yoo, Ki Eun
    Kim, Jeong Han
    Nam, Seok Jin
    Yang, Jung Hyun
    Lee, Sang Jin
    Yoo, Keon Hee
    Sung, Ki Woong
    Koo, Hong Hoe
    Im, Young-Hyuck
    [J]. JOURNAL OF KOREAN MEDICAL SCIENCE, 2007, 22 : S17 - S23
  • [5] Outcomes of Contemporary Treatment of Occult Primary Breast Cancer
    Durgan, D. M.
    Hoskin, T.
    Tonneson, J. E.
    Day, C.
    Hieken, T. J.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 1) : S56 - S56
  • [6] Treatment for Patients With Unknown Primary Carcinoma and Unfavorable Prognostic Factors
    Greco, F. Anthony
    Pavlidis, Nicholas
    [J]. SEMINARS IN ONCOLOGY, 2009, 36 (01) : 65 - 74
  • [7] Treatment outcomes and prognostic factors in nonmetastatic metaplastic breast cancer patients: a multicenter retrospective cohort study
    Puskulluoglu, Mirosiawa
    Konieczna, Aleksandra
    Swiderska, Katarzyna
    Streb, Joanna
    Pieniazek, Maigorzata
    Grela-Wojewoda, Alek-sandra
    Pacholczak-Madej, Renata
    Mucha-Maiecka, Anna
    Mitus, Jerzy W.
    Szpor, Joanna
    Kunkiel, Michai
    Rudzinska, Agnieszka
    Jarzab, Michai
    Ziobro, Marek
    [J]. ACTA ONCOLOGICA, 2024, 63 : 620 - 635
  • [8] Clinical Characteristics, Prognostic Factors and Treatment Outcomes of Patients with Bone-Only Metastatic Breast Cancer
    Marie, Lina
    Braik, Dina
    Abdel-Razeq, Nayef
    Abu-Fares, Hala
    Al-Thunaibat, Ahmad
    Abdel-Razeq, Hikmat
    [J]. CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 2519 - 2531
  • [9] TREATMENT OUTCOMES AND PROGNOSTIC FACTORS FOR PATIENTS WITH BRAIN METASTASES FROM BREAST CANCER: A MULTICENTER COHORT ANALYSIS
    Masuda, N.
    Niikura, N.
    Hayashi, N.
    Takashima, S.
    Nakamura, R.
    Watanabe, K.
    Kanbayashi, C.
    Ishida, M.
    Hozumi, Y.
    Tsuneizumi, M.
    Kondo, N.
    Naito, Y.
    Honda, Y.
    Matsui, A.
    Fujisawa, T.
    Oshitanai, R.
    Yasojima, H.
    Tokuda, Y.
    Saji, S.
    Iwata, H.
    [J]. ANNALS OF ONCOLOGY, 2014, 25
  • [10] Leptomeningeal Disease in Breast Cancer: Pre-Treatment Prognostic Factors and Outcomes
    Milligan, M. G.
    Aitelli, A.
    Mehan, W. A.
    Shi, D. D.
    Cagney, D. N.
    Oh, K. S.
    Wang, N.
    Brastianos, P.
    Moy, B.
    Lin, N. U.
    Shih, H. A.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E574 - E575